Sean Coffey1, Brian Cox2, Michael J A Williams3. 1. Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand; OxVALVE Study, Oxford University Hospitals, Oxford, United Kingdom. Electronic address: sean.coffey@ouh.nhs.uk. 2. Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. 3. Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Abstract
BACKGROUND: Valvular heart disease (VHD) is an increasingly common problem in clinical practice. With the development of new but expensive therapeutic options, health care systems require timely epidemiological information on VHD. We sought to determine the mortality burden of VHD and how it has changed over time. METHODS: Population level data from the United States (US) from 1979 to 2009 were used to examine trends in VHD mortality rates over time. Our outcome measure was death, where the primary cause of death was valvular heart disease. RESULTS: The annual number of VHD deaths increased from 15,054 in 1979 to 26,663 in 2009, an increase of on average 2.8% in the US each year (R(2) = 0.97, P < .001). The total VHD mortality rate increased with older age and male sex. There was little overall change in age- and sex-adjusted total VHD mortality rate over time (mortality rate ratio per year 0.999, 95% confidence interval 0.999 to 0.999, P < .001). Non-rheumatic aortic valve disease accounted for 45.2% of all VHD deaths. Adjusted mortality rates for aortic valve disease, mitral valve disease and endocarditis increased (P < .001), while that for rheumatic heart disease decreased (P < .001). If VHD mortality rates remain stable, deaths due to VHD are projected to double over the next 25 years. CONCLUSIONS: Despite improvements in mortality rates for other major conditions and in surgical outcomes for VHD, adjusted VHD mortality rates showed minimal change over the 31 years examined. The ageing population is driving a marked increase in the number of deaths due to VHD.
BACKGROUND:Valvular heart disease (VHD) is an increasingly common problem in clinical practice. With the development of new but expensive therapeutic options, health care systems require timely epidemiological information on VHD. We sought to determine the mortality burden of VHD and how it has changed over time. METHODS: Population level data from the United States (US) from 1979 to 2009 were used to examine trends in VHD mortality rates over time. Our outcome measure was death, where the primary cause of death was valvular heart disease. RESULTS: The annual number of VHD deaths increased from 15,054 in 1979 to 26,663 in 2009, an increase of on average 2.8% in the US each year (R(2) = 0.97, P < .001). The total VHD mortality rate increased with older age and male sex. There was little overall change in age- and sex-adjusted total VHD mortality rate over time (mortality rate ratio per year 0.999, 95% confidence interval 0.999 to 0.999, P < .001). Non-rheumatic aortic valve disease accounted for 45.2% of all VHD deaths. Adjusted mortality rates for aortic valve disease, mitral valve disease and endocarditis increased (P < .001), while that for rheumatic heart disease decreased (P < .001). If VHD mortality rates remain stable, deaths due to VHD are projected to double over the next 25 years. CONCLUSIONS: Despite improvements in mortality rates for other major conditions and in surgical outcomes for VHD, adjusted VHD mortality rates showed minimal change over the 31 years examined. The ageing population is driving a marked increase in the number of deaths due to VHD.
Authors: Muhammad Shariq Usman; Harriette G C Van Spall; Stephen J Greene; Ambarish Pandey; Darren K McGuire; Ziad A Ali; Robert J Mentz; Gregg C Fonarow; John A Spertus; Stefan D Anker; Javed Butler; Stefan K James; Muhammad Shahzeb Khan Journal: Nat Rev Cardiol Date: 2022-05-17 Impact factor: 49.421
Authors: John S Chorba; Avi M Shapiro; Le Le; John Maidens; John Prince; Steve Pham; Mia M Kanzawa; Daniel N Barbosa; Caroline Currie; Catherine Brooks; Brent E White; Anna Huskin; Jason Paek; Jack Geocaris; Dinatu Elnathan; Ria Ronquillo; Roy Kim; Zenith H Alam; Vaikom S Mahadevan; Sophie G Fuller; Grant W Stalker; Sara A Bravo; Dina Jean; John J Lee; Medeona Gjergjindreaj; Christos G Mihos; Steven T Forman; Subramaniam Venkatraman; Patrick M McCarthy; James D Thomas Journal: J Am Heart Assoc Date: 2021-04-26 Impact factor: 5.501
Authors: Sean Coffey; Michael J A Williams; L Vicky Phillips; Ivor F Galvin; Richard W Bunton; Gregory T Jones Journal: Sci Rep Date: 2016-11-23 Impact factor: 4.379
Authors: F van den Brink; J Hasenaar; V Winia; M Klomp; B Van Vlies; D Nicastia; B Groenmeijer; R Braam; W Jaarsma; A J Funke Kupper Journal: Neth Heart J Date: 2016-12 Impact factor: 2.380